Illustrative image – not actual.
Vivint Pharma plans to establish an injectables manufacturing facility in Genome Valley, Hyderabad. The company will make an investment of Rs 400 crore towards setting up its first manufacturing plant, and has acquired 5.5 acres of land in Genome Valley.
The announcement was made during a high-level meeting with the Chief Minister of Telangana, A Revanth Reddy and his team in the US. The project has the potential to employ 1,000 people.
The new facility will focus on the development and production of high-quality injectable drugs in the oncology and critical care space and will cater to both domestic and international markets.
The company has an R&D centre in Genome Valley , infusing about Rs 70 crore in the facility.
